12th INTERNATIONAL CONFERENCE ON ALZHEIMER'S DRUG DISCOVERY

September 26-27, 2011   Jersey City, NJ, USA (across from NYC on the Hudson)

Presented by the Alzheimer's Drug Discovery Foundation

 

  HOME

  PROGRAM

  SPEAKERS

  SCHOLARSHIPS

  VENUE/ACCOMMODATIONS

  SPONSORSHIP/EXHIBIT

  SUPPORTERS

  CONTACT

ABOUT THIS MEETING

 

This annual ADDF conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias.  The ADDF’s funded investigators and top level scientists in the field will present their current research, provide progress updates and stimulate discussion. The conference offers ample opportunities for collaboration and partnering. 

 

OBJECTIVES

 

Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.

Increase networking opportunities for scientists to share information and resources.

Foster interdisciplinary and public-private partnerships and alliances.

 

TARGET AUDIENCE

 

The 2010 edition of this conference attracted attendees from around the globe.  Attendees included:

 

Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases or CNS

Business development and licensing professionals

Alliance management professionals

Venture capitalists and other investors.

 

SCHOLARSHIPS

 

The Alzheimer’s Drug Discovery Foundation announces its 2011 ADDF Young Investigator Scholarship winners. 

 

 

 

IMPORTANT DATES

 

September 21, 2011 - Online registration closes

 

EXHIBIT AND SPONSORSHIP

 

The 12th International Conference on Alzheimer’s Disease Drug Discovery offers a great opportunity to expand your company's visibility among the registrants by becoming a conference sponsor and/or exhibitor.  

Review the ample options and contact us today!

 

 

 

 

  © 2011 WEF